Some regulatory teams in the biopharma industry may be left on tenterhooks as they go into overtime waiting for official word on their drug applications. Hurricane Sandy put a crimp in the FDA's schedule. The agency--closed on the 29th and 30th of October--says it may have to tap the brakes on some drug and device applications, with a two-day delay on some drug and device decisions due after October 31. Story